Mumbai · London · Dubai

From the pharmacy of the world to your tender desk.

M Care is an Indian-owned pharmaceutical export house supplying WHO-GMP and EU-GMP medicines, biologicals and surgical consumables to hospitals, importers and government tender desks across the United Kingdom, the GCC, and Africa, with destination-ready dossiers, validated cold-chain, and a single named account manager on every shipment.

165,000+ SKU portfolio across partner panel
18 Therapeutic areas
46+ Export markets live
24h Quote turnaround
WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners ISO 9001:2015 SGS GDP Certified Pharmexcil RCMC FIEO Member Cold-chain validated CTD / eCTD ready

Rooted in the world's pharmacy

India supplies ~60% of the world's vaccines and the largest share of quality-assured generics outside the US. That is the manufacturing base we buy against, then QA, dossier and ship on your behalf.

Regulator-ready, destination-first

CTD/eCTD dossiers written for MHRA, EMA, SFDA, MoH-UAE, NAFDAC and the rest of the regulators we ship into, not a generic template repurposed page-by-page.

One named person on every order

No call-centre triage, no vanishing reply chains. Your Mumbai desk knows your molecule, your market, your pack-size preference and your customs broker by name.

Three desks. Forty-six markets.

A network across forty-six markets, anchored in three desks.

UK · EUROPE CENTRAL ASIA · CAUCASUS AFRICA LATAM ASEAN · SOUTH ASIA UNITED KINGDOM London · UK · EU · Commonwealth UAE Dubai · GCC · East Africa INDIA Mumbai · HQ · Sourcing · QA · Dispatch

Three desks. Forty-six destinations. One signal across the network. Browse all markets

Top export markets

Eight markets, three continents, one Mumbai desk.

NHS Specials in the UK, BfArM-recognised imports into Germany, GCC ministry-of-health tenders, NAFDAC Nigeria and SAHPRA South Africa. Live regulator dossiers, validated cold-chain lanes from Mumbai, and named procurement bodies on every card.

Browse all 46 markets

Therapeutic portfolio

Depth where you need it. Breadth where you don't.

Eighteen therapeutic categories, 165,000+ SKU portfolio, every line traceable to a named WHO-GMP or EU-GMP manufacturing site.

From the field

Three recent shipment patterns.

UK Specials, docetaxel shortage window. Reg. 167 named-patient consignment closed the licensed-source gap in 11 days end-to-end. Document pack pre-built; cold-chain on the BOM-LHR lane.

UK MHRA-licensed Specials importer 2024 · 240 vials · anonymised at customer request

Gulf hospital, biological cold-chain. Active-shipper consignment, 72-hour BOM-DXB lane. Continuous IoT logging in transit. Logger record: zero excursions outside the 2-8°C band.

Gulf university hospital network 2025 · 4-shipper pallet · 0 excursions · anonymised

NUPCO central tender response. 18-day biosimilar tender window. CTD dossier harmonised to GHC central format; SFDA stability appendix; Arabic-language SmPC. Response went on day 14.

NUPCO biosimilar tender (Saudi Arabia) 2025 · GHC central dossier · day 14 of 18

Buyer references available against signed mutual NDA. Direct introduction facilitated where a prospective buyer's diligence requires a peer reference.

Start the conversation

Tell us which molecule, which market, which volume.

One working day to a written reply with price, availability and regulatory status for your destination. No call-centre triage. No sales funnel. Just a human in Mumbai with the answer.

Request a quote Request data package Browse portfolio